idebenone has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hui, C | 1 |
| Tomilov, A | 1 |
| Garcia, C | 1 |
| Jiang, X | 1 |
| Fash, DM | 1 |
| Khdour, OM | 1 |
| Rosso, C | 1 |
| Filippini, G | 1 |
| Prato, M | 1 |
| Graham, J | 1 |
| Hecht, S | 1 |
| Havel, P | 1 |
| Cortopassi, G | 1 |
| Dassano, A | 1 |
| Loretelli, C | 1 |
| Fiorina, P | 1 |
2 other studies available for idebenone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Novel idebenone analogs block Shc's access to insulin receptor to improve insulin sensitivity.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Insulin Resistance; Mi | 2020 |
Idebenone and T2D: A new insulin-sensitizing drug for personalized therapy.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Precision Medicine; Src | 2019 |